(CTN News) – Sanofi is expected to invest between 1.3 billion and 1.5 billion euros in its Frankfurt production unit, according to Reuters and Handelsblatt. The insulin brand Lantus is manufactured at this plant, which is solely responsible for its production. In the past, Sanofi had revealed that it had explored relocating its Lantus production […]
Go to Source
Author: Salman Ahmad